Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Hemic or immune system
Reexamination Certificate
2007-10-16
2007-10-16
Belyavskyi, Michail (Department: 1644)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Hemic or immune system
C514S885000
Reexamination Certificate
active
10388964
ABSTRACT:
The present invention is directed to methods for delivering cells to a target tissue in a mammal using glycoconjugate to traffic the cell to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal.
REFERENCES:
patent: 5089604 (1992-02-01), Washino et al.
patent: 5346696 (1994-09-01), Kim et al.
patent: 5679323 (1997-10-01), Menz et al.
patent: WO 03/077864 (2003-09-01), None
patent: WO 03/077865 (2003-09-01), None
Hamano, Teruaki et al.; “Studies on the Kinetics of Hemopoietic Stem Cells and Immune Responses to the Hapten-Carrier Conjugate”;The Journal of Immunology1979 vol. 123 No. 3, pp. 1371-1375.
Nomura, Yoshio et al.; “Targeted gene delivery to the hepatocytes by asialoglycoprotein receptormediated endocytosis”;Environmental Medicine1995 vol. 39 No. 1, pp. 17-20.
Teranishi, K. et al.; “Depletion of Anti-Gal Antibodies in Baboons by Intravenous Therapy with Bovine Serum Albumin Conjugated to Gal Oligosaccharides”;Transplantation2002 vol. 73 No. 1, pp. 129-139.
Ashwell, et al. “The Role of Surface Carbohydrates in the Hepatic Recognition and Transport of Circulating Glycoproteins,”Advances in Enzymology and Related Areas of Molecular Biology, vol. 41, pp. 99-128, John Wiley & Sons, New York, (1974).
Ashwell, et al., “Carbohydrate-Specific Receptors of the Liver,”Ann. Rev. Biochem., vol. 51, pp. 531-554, (1982).
Bennett, et al., “Immunosuppression by Human Plasma α1-Acid Glycoprotein: Importance of the Carbohydratre Moiety,”Proc. Natl. Acad. Sci., vol. 77, No. 10, pp. 6109-6116, USA, (Oct. 1980).
Costello, et al., “Inhibition of Neutrophil Activation by α1-Acid Glycoprotein,”Clin. Exp. Immunol, vol. 55, pp. 465-472, (1984).
Costello, et al., “Inhibition of Platelet Aggregation by Native and Desialised Alpha-1 Acid Glycoprotein,”Nature, vol. 281, pp. 677-678, (Oct. 25, 1979).
Eror, et al., “Antiinflammatory Effects of Soluble Complement Receptor Type 1 Promote Rapid Recovery of Ischemia/Reperfusion Injury in Rat Small Intestine,”Clinical Immunology, vol. 90, No. 2, pp. 266-275, (1999).
Gao, et al., “The Dynamic in Vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion,”Cells Tissues Organs, vol. 169, pp. 12-20, (2001).
Kilgore, et al., “The Complement System in Myocardial Ischaemia/Reperfusion Injury,”Cardiovascular Research, vol. 28, pp. 437-444, (1994).
Libert, et al., “Protection by α1-Acid Glycoprotein against Tumor Necrosis Factor-Induced Lethality,”J. Exp. Med., vol. 180, pp. 1571-1575, The Rockefeller University Press, (Oct. 1994).
Martino, et al., “The Fate of Human Peripheral Blood Lymphocytes after Transplantation into SCID Mice,”Eur. J. Immunol, vol. 23, pp. 1023-1028, (1993).
Morell, et al., “Physical and Chemical Studies on Ceruloplasmin,”The Journal of Biological Chemistry, vol. 243, No. 1, pp. 155-159, USA, (Jan. 10, 1968).
Morrison, et al., “More of Less Hematopoietic Stem Cells,”Nature Medicine, vol. 2 No. 12, pp. 1281-1282, (Dec. 1996).
Muchitsch, et al., “Effects of Human Alpha-1-Acid Glycoprotein on Aminonucleoside-Induced Minimal Change Nephrosis in Rats,”Nephron, vol. 81, pp. 194-199, (1999).
Muchitsch, et al., “In vivo Effect of α1-Acid Glycoprotein on Experimentally Enhanced Capillary Permeability in Guinea-Pig Skin,”Arch. Int. Pharmacodyn, vol. 331, pp. 313-321, (1996).
Pereira, et al., “Cultured Adherent Cells from Marrow can Serve as Long-Lasting Precursor Cells for Bone, Cartilage, and Lung in Irradiated Mice,”Proc. Natl. Acad. Sci., vol. 92, pp. 4857-4861, USA, (May 1995).
Samlowski, et al., “Bone Marrow Engraftment Efficiency is Enhanced by Competitive Inhibition of the Hepatic Asialoglycoprotein Receptor,”Proc. Natl. Acad. Sci., vol. 82, pp. 2508-2512, (Apr. 1985).
Samlowski, et al., “Studies on the Liver Sequestration of Lymphocytes Bearing Membrane-Associated Galactose-Terminal Glycoconjugates: Reversal with Agents That Effectively Compete for the Asialoglycoprotein Receptor,”Cellular Immunology, vol. 88, pp. 309-322, Academic Press, Inc., (1984).
Scheinberg, et al., “Hepatic Removal of Circulating Proteins,”Problems in Liver Diseases, Chapter 29, pp. 279-285, Stratton Intercontinental Medical Book Corp., New York, (1979).
Schnitzer, et al., “Quantitation of Specific Binding of Orosomucoid to Cultured Microvascular Endothelium: Role in Capillary Permeability,”Am. J. Physiol, pp. H48-H55, The American Physiological Society, (1992).
Simmons, et al., “The Mobilization of Primitive Hemopoietic Progenitors into the Peripheral Blood,”Stem Cells, vol. 12 (suppl 1), pp. 187-202, (1994).
Van Den Hamer, “Physical and Chemical Studies on Ceruloplasmin,”The Journal of Biological Chemistry, vol. 245, No. 17, pp. 4397-4402, USA, (Sep. 10, 1970).
Belyavskyi Michail
BioTechnology Law Group
Chambers Daniel M.
The United States of America as Represented by the Department of
LandOfFree
Methods and compositions for directing cells to target organs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for directing cells to target organs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for directing cells to target organs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3893600